Showing results (161-170 of 199) with videos related to
Sort By:
Pageof 20
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
A randomized trial of postoperative five-versus three-drug chemotherapy after mastectomy: a Cancer and Leukemia Group B (CALGB) studyR B Weiss, D C Tormey, F Holland, et al.American Journal of Clinical Oncology|December 1, 1988
ECOG phase II trials of MGBG, chlorozotocin, COM multidrug therapy in advanced measurable colorectal cancerH O Douglass, M Lefkopoulou, H L Davis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of deathF J Cummings, R Gray, D C Tormey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trialD C Tormey, R Gray, M D Abeloff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancerG Falkson, R S Gelman, R Dreicer, et al.American Journal of Clinical Oncology|February 1, 1991
A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancerD T Ransom, D Neuberg, C L Loprinzi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatmentG Falkson, R S Gelman, K J Pandya, et al.Journal of the National Cancer Institute. Monographs|January 1, 1992
Chemotherapy versus observation in high-risk node-negative breast cancer patientsE G Mansour, L Eudey, D C Tormey, et al.The New England Journal of Medicine|February 23, 1989
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup studyE G Mansour, R Gray, A H Shatila, et al.Cancer Treatment Reports|October 1, 1987
Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agentsR S Gelman, D C Tormey, R Betensky, et al.Pageof 20